Peng Z, Jia Q, Mao J, Luo X, Huang A, Zheng H
Front Psychiatry. 2025; 15:1439727.
PMID: 39876994
PMC: 11773674.
DOI: 10.3389/fpsyt.2024.1439727.
Huminska-Lisowska K
Int J Mol Sci. 2024; 25(21).
PMID: 39519153
PMC: 11546834.
DOI: 10.3390/ijms252111602.
Gold M, Blum K, Bowirrat A, Pinhasov A, Bagchi D, Dennen C
INNOSC Theranostics Pharmacol Sci. 2024; 7(3).
PMID: 39119149
PMC: 11308626.
DOI: 10.36922/itps.1918.
Zhang M, Zhao C, Mao Z, Zhang M, Xing X
PLoS One. 2024; 19(7):e0307717.
PMID: 39047016
PMC: 11268701.
DOI: 10.1371/journal.pone.0307717.
Powell A, Hanna C, Sajjad M, Yao R, Blum K, Gold M
J Pers Med. 2024; 14(5).
PMID: 38793082
PMC: 11122626.
DOI: 10.3390/jpm14050500.
Addressing cortex dysregulation in youth through brain health check coaching and prophylactic brain development.
Blum K, Braverman E, Gold M, Dennen C, Baron D, Thanos P
INNOSC Theranostics Pharmacol Sci. 2024; 7(2):1472.
PMID: 38766548
PMC: 11100020.
DOI: 10.36922/itps.1472.
Summary Document Research on RDS Anti-addiction Modeling: Annotated Bibliography.
Blum K, Baron D, Mclaughlin T, Thanos P, Dennen C, Ceccanti M
J Addict Psychiatry. 2024; 8(1):1-33.
PMID: 38765881
PMC: 11100022.
Exercise Modifies the Brain Metabolic Response to Chronic Cocaine Exposure Inhibiting the Stria Terminalis.
Hanna C, Yao R, Sajjad M, Gold M, Blum K, Thanos P
Brain Sci. 2023; 13(12).
PMID: 38137153
PMC: 10742065.
DOI: 10.3390/brainsci13121705.
Can We Combat Reward Deficiency Behaviors (RDS) including Substance Use Disorder (SUD) through Genetic Risk Screening coupled with Precision Pro-Dopamine Regulation by Algorithmic matched Polymorphic Allelic Risks.
Blum K, Baron D, Hauser M, Badgaiyan R, Downs B, Siwicki D
Madridge J Mol Biol. 2023; 1(1):1-3.
PMID: 37736119
PMC: 10512439.
The First Exploratory Personalized Medicine Approach to Improve Bariatric Surgery Outcomes Utilizing Psychosocial and Genetic Risk Assessments: Encouraging Clinical Research.
Thanos P, Hanna C, Mihalkovic A, Hoffman A, Posner A, Busch J
J Pers Med. 2023; 13(7).
PMID: 37511777
PMC: 10381606.
DOI: 10.3390/jpm13071164.
Transmodulation of Dopaminergic Signaling to Mitigate Hypodopminergia and Pharmaceutical Opioid-Induced Hyperalgesia.
Brewer R, Blum K, Bowirrat A, Modestino E, Baron D, Badgaiyan R
Curr Psychopharmacol. 2023; 9(3):164-184.
PMID: 37361136
PMC: 10288629.
DOI: 10.2174/2211556009999200628093231.
Sex differences in susceptibility to substance use disorder: Role for X chromosome inactivation and escape?.
Krueger K, Lamenza F, Gu H, El-Hodiri H, Wester J, Oberdick J
Mol Cell Neurosci. 2023; 125:103859.
PMID: 37207894
PMC: 10286730.
DOI: 10.1016/j.mcn.2023.103859.
Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline....
Ceccanti M, Blum K, Bowirrat A, Dennen C, Braverman E, Baron D
J Pers Med. 2022; 12(12).
PMID: 36556236
PMC: 9782293.
DOI: 10.3390/jpm12122015.
Exercise Modulates Brain Glucose Utilization Response to Acute Cocaine.
Hanna C, Hamilton J, Blum K, Badgaiyan R, Thanos P
J Pers Med. 2022; 12(12).
PMID: 36556197
PMC: 9788493.
DOI: 10.3390/jpm12121976.
"Preaddiction" construct and reward deficiency syndrome: genetic link via dopaminergic dysregulation.
Blum K, Elman I, Dennen C, Mclaughlin T, Thanos P, Baron D
Ann Transl Med. 2022; 10(21):1181.
PMID: 36467361
PMC: 9708493.
DOI: 10.21037/atm-2022-32.
Proposing FDA consideration for the treatment and prophylaxis of opioid and psychostimulant abuse to incorporate the induction of DNA guided dopamine homeostasis: Anti-reward deficiency restoration solution (ARDS).
Blum K, Giordano J, Baron D, Mclaughlin T, Badgaiyan R
J Syst Integr Neurosci. 2022; 8.
PMID: 36407844
PMC: 9670280.
DOI: 10.15761/JSIN.1000253.
Triple Diagnosis of Attention-Deficit/Hyperactivity Disorder with Coexisting Bipolar and Alcohol Use Disorders: Clinical Aspects and Pharmacological Treatments.
Weiss F, Tidona S, Carli M, Perugi G, Scarselli M
Curr Neuropharmacol. 2022; 21(7):1467-1476.
PMID: 36306451
PMC: 10472804.
DOI: 10.2174/1570159X20666220830154002.
Dopaminylation in Psychostimulant Use Disorder Protects Against Psychostimulant Seeking Behavior by Normalizing Nucleus Accumbens (NAc) Dopamine Expression.
Blum K, Gold M, Cadet J, Baron D, Bowirrat A, Thanos P
Curr Psychopharmacol. 2022; 11(1):11-17.
PMID: 36046837
PMC: 9426774.
DOI: 10.2174/2211556009666210108112737.
Prenatal Effects of Nicotine on Obesity Risks: A Narrative Review.
White O, Roeder N, Blum K, Eiden R, Thanos P
Int J Environ Res Public Health. 2022; 19(15).
PMID: 35954830
PMC: 9368674.
DOI: 10.3390/ijerph19159477.
Researching Mitigation of Alcohol Binge Drinking in Polydrug Abuse: KCNK13 and RASGRF2 Gene(s) Risk Polymorphisms Coupled with Genetic Addiction Risk Severity (GARS) Guiding Precision Pro-Dopamine Regulation.
Blum K, Brodie M, Pandey S, Cadet J, Gupta A, Elman I
J Pers Med. 2022; 12(6).
PMID: 35743793
PMC: 9224860.
DOI: 10.3390/jpm12061009.